Pandemic Influenza Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Pandemic Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pandemic Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pandemic Influenza Vaccine Overall Market Size
2.1 Global Pandemic Influenza Vaccine Market Size: 2022 VS 2029
2.2 Global Pandemic Influenza Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pandemic Influenza Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Pandemic Influenza Vaccine Players in Global Market
3.2 Top Global Pandemic Influenza Vaccine Companies Ranked by Revenue
3.3 Global Pandemic Influenza Vaccine Revenue by Companies
3.4 Global Pandemic Influenza Vaccine Sales by Companies
3.5 Global Pandemic Influenza Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pandemic Influenza Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pandemic Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pandemic Influenza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Pandemic Influenza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Pandemic Influenza Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pandemic Influenza Vaccine Market Size Markets, 2022 & 2029
4.1.2 Whole Virus Vaccines
4.1.3 Split Virus Vaccines
4.1.4 Subunit Vaccines
4.2 By Type - Global Pandemic Influenza Vaccine Revenue & Forecasts
4.2.1 By Type - Global Pandemic Influenza Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Pandemic Influenza Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Pandemic Influenza Vaccine Revenue Market Share, 2018-2029
4.3 By Type - Global Pandemic Influenza Vaccine Sales & Forecasts
4.3.1 By Type - Global Pandemic Influenza Vaccine Sales, 2018-2023
4.3.2 By Type - Global Pandemic Influenza Vaccine Sales, 2024-2029
4.3.3 By Type - Global Pandemic Influenza Vaccine Sales Market Share, 2018-2029
4.4 By Type - Global Pandemic Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pandemic Influenza Vaccine Market Size, 2022 & 2029
5.1.2 For Children (6 months to 3 years)
5.1.3 For Adults and Children over 3 years
5.2 By Application - Global Pandemic Influenza Vaccine Revenue & Forecasts
5.2.1 By Application - Global Pandemic Influenza Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Pandemic Influenza Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Pandemic Influenza Vaccine Revenue Market Share, 2018-2029
5.3 By Application - Global Pandemic Influenza Vaccine Sales & Forecasts
5.3.1 By Application - Global Pandemic Influenza Vaccine Sales, 2018-2023
5.3.2 By Application - Global Pandemic Influenza Vaccine Sales, 2024-2029
5.3.3 By Application - Global Pandemic Influenza Vaccine Sales Market Share, 2018-2029
5.4 By Application - Global Pandemic Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Pandemic Influenza Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Pandemic Influenza Vaccine Revenue & Forecasts
6.2.1 By Region - Global Pandemic Influenza Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Pandemic Influenza Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Pandemic Influenza Vaccine Revenue Market Share, 2018-2029
6.3 By Region - Global Pandemic Influenza Vaccine Sales & Forecasts
6.3.1 By Region - Global Pandemic Influenza Vaccine Sales, 2018-2023
6.3.2 By Region - Global Pandemic Influenza Vaccine Sales, 2024-2029
6.3.3 By Region - Global Pandemic Influenza Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Pandemic Influenza Vaccine Revenue, 2018-2029
6.4.2 By Country - North America Pandemic Influenza Vaccine Sales, 2018-2029
6.4.3 US Pandemic Influenza Vaccine Market Size, 2018-2029
6.4.4 Canada Pandemic Influenza Vaccine Market Size, 2018-2029
6.4.5 Mexico Pandemic Influenza Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Pandemic Influenza Vaccine Revenue, 2018-2029
6.5.2 By Country - Europe Pandemic Influenza Vaccine Sales, 2018-2029
6.5.3 Germany Pandemic Influenza Vaccine Market Size, 2018-2029
6.5.4 France Pandemic Influenza Vaccine Market Size, 2018-2029
6.5.5 U.K. Pandemic Influenza Vaccine Market Size, 2018-2029
6.5.6 Italy Pandemic Influenza Vaccine Market Size, 2018-2029
6.5.7 Russia Pandemic Influenza Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Pandemic Influenza Vaccine Market Size, 2018-2029
6.5.9 Benelux Pandemic Influenza Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Pandemic Influenza Vaccine Revenue, 2018-2029
6.6.2 By Region - Asia Pandemic Influenza Vaccine Sales, 2018-2029
6.6.3 China Pandemic Influenza Vaccine Market Size, 2018-2029
6.6.4 Japan Pandemic Influenza Vaccine Market Size, 2018-2029
6.6.5 South Korea Pandemic Influenza Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Pandemic Influenza Vaccine Market Size, 2018-2029
6.6.7 India Pandemic Influenza Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Pandemic Influenza Vaccine Revenue, 2018-2029
6.7.2 By Country - South America Pandemic Influenza Vaccine Sales, 2018-2029
6.7.3 Brazil Pandemic Influenza Vaccine Market Size, 2018-2029
6.7.4 Argentina Pandemic Influenza Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pandemic Influenza Vaccine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Pandemic Influenza Vaccine Sales, 2018-2029
6.8.3 Turkey Pandemic Influenza Vaccine Market Size, 2018-2029
6.8.4 Israel Pandemic Influenza Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Pandemic Influenza Vaccine Market Size, 2018-2029
6.8.6 UAE Pandemic Influenza Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CSL
7.1.1 CSL Company Summary
7.1.2 CSL Business Overview
7.1.3 CSL Pandemic Influenza Vaccine Major Product Offerings
7.1.4 CSL Pandemic Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 CSL Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Pandemic Influenza Vaccine Major Product Offerings
7.2.4 GSK Pandemic Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi Pasteur
7.3.1 Sanofi Pasteur Company Summary
7.3.2 Sanofi Pasteur Business Overview
7.3.3 Sanofi Pasteur Pandemic Influenza Vaccine Major Product Offerings
7.3.4 Sanofi Pasteur Pandemic Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Pasteur Key News & Latest Developments
7.4 Mylan
7.4.1 Mylan Company Summary
7.4.2 Mylan Business Overview
7.4.3 Mylan Pandemic Influenza Vaccine Major Product Offerings
7.4.4 Mylan Pandemic Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Mylan Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Pandemic Influenza Vaccine Major Product Offerings
7.5.4 AstraZeneca Pandemic Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Pandemic Influenza Vaccine Major Product Offerings
7.6.4 Pfizer Pandemic Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Pandemic Influenza Vaccine Major Product Offerings
7.7.4 Johnson & Johnson Pandemic Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
8 Global Pandemic Influenza Vaccine Production Capacity, Analysis
8.1 Global Pandemic Influenza Vaccine Production Capacity, 2018-2029
8.2 Pandemic Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pandemic Influenza Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pandemic Influenza Vaccine Supply Chain Analysis
10.1 Pandemic Influenza Vaccine Industry Value Chain
10.2 Pandemic Influenza Vaccine Upstream Market
10.3 Pandemic Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pandemic Influenza Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Pandemic Influenza Vaccine in Global Market
Table 2. Top Pandemic Influenza Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Pandemic Influenza Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Pandemic Influenza Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Pandemic Influenza Vaccine Sales by Companies, (K Doses), 2018-2023
Table 6. Global Pandemic Influenza Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Pandemic Influenza Vaccine Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Pandemic Influenza Vaccine Product Type
Table 9. List of Global Tier 1 Pandemic Influenza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pandemic Influenza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pandemic Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Pandemic Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Pandemic Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Pandemic Influenza Vaccine Sales (K Doses), 2018-2023
Table 15. By Type - Global Pandemic Influenza Vaccine Sales (K Doses), 2024-2029
Table 16. By Application ? Global Pandemic Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Pandemic Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Pandemic Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Pandemic Influenza Vaccine Sales (K Doses), 2018-2023
Table 20. By Application - Global Pandemic Influenza Vaccine Sales (K Doses), 2024-2029
Table 21. By Region ? Global Pandemic Influenza Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Pandemic Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Pandemic Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Pandemic Influenza Vaccine Sales (K Doses), 2018-2023
Table 25. By Region - Global Pandemic Influenza Vaccine Sales (K Doses), 2024-2029
Table 26. By Country - North America Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Pandemic Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Pandemic Influenza Vaccine Sales, (K Doses), 2018-2023
Table 29. By Country - North America Pandemic Influenza Vaccine Sales, (K Doses), 2024-2029
Table 30. By Country - Europe Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Pandemic Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Pandemic Influenza Vaccine Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Pandemic Influenza Vaccine Sales, (K Doses), 2024-2029
Table 34. By Region - Asia Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Pandemic Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Pandemic Influenza Vaccine Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Pandemic Influenza Vaccine Sales, (K Doses), 2024-2029
Table 38. By Country - South America Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Pandemic Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Pandemic Influenza Vaccine Sales, (K Doses), 2018-2023
Table 41. By Country - South America Pandemic Influenza Vaccine Sales, (K Doses), 2024-2029
Table 42. By Country - Middle East & Africa Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Pandemic Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Pandemic Influenza Vaccine Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Pandemic Influenza Vaccine Sales, (K Doses), 2024-2029
Table 46. CSL Company Summary
Table 47. CSL Pandemic Influenza Vaccine Product Offerings
Table 48. CSL Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. CSL Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Pandemic Influenza Vaccine Product Offerings
Table 52. GSK Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. Sanofi Pasteur Company Summary
Table 55. Sanofi Pasteur Pandemic Influenza Vaccine Product Offerings
Table 56. Sanofi Pasteur Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Sanofi Pasteur Key News & Latest Developments
Table 58. Mylan Company Summary
Table 59. Mylan Pandemic Influenza Vaccine Product Offerings
Table 60. Mylan Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. Mylan Key News & Latest Developments
Table 62. AstraZeneca Company Summary
Table 63. AstraZeneca Pandemic Influenza Vaccine Product Offerings
Table 64. AstraZeneca Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. AstraZeneca Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Pandemic Influenza Vaccine Product Offerings
Table 68. Pfizer Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Johnson & Johnson Company Summary
Table 71. Johnson & Johnson Pandemic Influenza Vaccine Product Offerings
Table 72. Johnson & Johnson Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. Johnson & Johnson Key News & Latest Developments
Table 74. Pandemic Influenza Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 75. Global Pandemic Influenza Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Pandemic Influenza Vaccine Production by Region, 2018-2023 (K Doses)
Table 77. Global Pandemic Influenza Vaccine Production by Region, 2024-2029 (K Doses)
Table 78. Pandemic Influenza Vaccine Market Opportunities & Trends in Global Market
Table 79. Pandemic Influenza Vaccine Market Drivers in Global Market
Table 80. Pandemic Influenza Vaccine Market Restraints in Global Market
Table 81. Pandemic Influenza Vaccine Raw Materials
Table 82. Pandemic Influenza Vaccine Raw Materials Suppliers in Global Market
Table 83. Typical Pandemic Influenza Vaccine Downstream
Table 84. Pandemic Influenza Vaccine Downstream Clients in Global Market
Table 85. Pandemic Influenza Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pandemic Influenza Vaccine Segment by Type in 2022
Figure 2. Pandemic Influenza Vaccine Segment by Application in 2022
Figure 3. Global Pandemic Influenza Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pandemic Influenza Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pandemic Influenza Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Pandemic Influenza Vaccine Sales in Global Market: 2018-2029 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Pandemic Influenza Vaccine Revenue in 2022
Figure 9. By Type - Global Pandemic Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Pandemic Influenza Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Pandemic Influenza Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Pandemic Influenza Vaccine Price (USD/Dose), 2018-2029
Figure 13. By Application - Global Pandemic Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Pandemic Influenza Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Pandemic Influenza Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Pandemic Influenza Vaccine Price (USD/Dose), 2018-2029
Figure 17. By Region - Global Pandemic Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Pandemic Influenza Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Pandemic Influenza Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Pandemic Influenza Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Pandemic Influenza Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Pandemic Influenza Vaccine Sales Market Share, 2018-2029
Figure 23. US Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Pandemic Influenza Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Pandemic Influenza Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Pandemic Influenza Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Pandemic Influenza Vaccine Sales Market Share, 2018-2029
Figure 37. China Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Pandemic Influenza Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Pandemic Influenza Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Pandemic Influenza Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Pandemic Influenza Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Pandemic Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Pandemic Influenza Vaccine Production Capacity (K Doses), 2018-2029
Figure 53. The Percentage of Production Pandemic Influenza Vaccine by Region, 2022 VS 2029
Figure 54. Pandemic Influenza Vaccine Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
